Momenta Phamaceuticals, Inc. (MNTA) Misses Q4 FFO by 7c
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Financial Fact:
Total collaboration revenue: 29.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Total collaboration revenue: 29.14M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Momenta Phamaceuticals, Inc. (NASDAQ: MNTA) reported Q4 FFO of $0.20, $0.07 worse than the analyst estimate of $0.27.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
For earnings history and earnings-related data on Momenta Phamaceuticals, Inc. (MNTA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- Vireo Growth completes acquisition of C21 Investments
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
